- Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate. Corbett, T.H., LoRusso, P., Demchick, L., Simpson, C., Pugh, S., White, K., Kushner, J., Polin, L., Meyer, J., Czarnecki, J., Heilbrun, L., Horwitz, J.P., Gross, J.L., Behrens, C.H., Harrison, B.A., McRipley, R.J., Trainor, G. Investigational new drugs. (1998)